STOCK TITAN

Aemetis Reports Revenues of $81 Million for the Third Quarter 2024

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Negative)
Tags

Aemetis (NASDAQ: AMTX) reported Q3 2024 revenues of $81.4 million, a 19% increase from Q3 2023. Revenue breakdown: California Ethanol business generated $45.0 million, India Biodiesel business $32.2 million, and Dairy Renewable Natural Gas (RNG) business $4.2 million. The company reported a gross profit of $3.9 million and a net loss of $17.9 million. The Keyes plant produced 15.5 million gallons of ethanol, while the Dairy Natural Gas segment sold 85,993 MMBtu from nine operating dairy digesters. The company's cash position at quarter-end was $296 thousand, with $4.5 million invested in capital projects during Q3 2024.

Aemetis (NASDAQ: AMTX) ha riportato ricavi per il terzo trimestre del 2024 pari a 81,4 milioni di dollari, con un incremento del 19% rispetto al terzo trimestre del 2023. Suddivisione dei ricavi: l'attività di etanolo in California ha generato 45,0 milioni di dollari, l'attività di biodiesel in India 32,2 milioni di dollari e l'attività di gas naturale rinnovabile (RNG) derivato dai prodotti lattiero-caseari 4,2 milioni di dollari. L'azienda ha registrato un utile lordo di 3,9 milioni di dollari e una perdita netta di 17,9 milioni di dollari. L'impianto Keyes ha prodotto 15,5 milioni di galloni di etanolo, mentre il segmento del gas naturale dai prodotti lattiero-caseari ha venduto 85.993 MMBtu da nove digestori operativi. La posizione di cassa dell'azienda alla fine del trimestre era di 296 mila dollari, con 4,5 milioni di dollari investiti in progetti di capitale durante il terzo trimestre del 2024.

Aemetis (NASDAQ: AMTX) reportó ingresos de $81.4 millones en el tercer trimestre de 2024, un aumento del 19% en comparación con el tercer trimestre de 2023. Desglose de ingresos: el negocio de etanol en California generó 45.0 millones de dólares, el negocio de biodiésel en India 32.2 millones de dólares y el negocio de gas natural renovable (RNG) de productos lácteos 4.2 millones de dólares. La compañía reportó una ganancia bruta de 3.9 millones de dólares y una pérdida neta de 17.9 millones de dólares. La planta Keyes produjo 15.5 millones de galones de etanol, mientras que el segmento de gas natural de lácteos vendió 85,993 MMBtu de nueve digestores lácteos en operación. La posición de efectivo de la compañía al final del trimestre era de 296 mil dólares, con 4.5 millones de dólares invertidos en proyectos de capital durante el tercer trimestre de 2024.

Aemetis (NASDAQ: AMTX)는 2024년 3분기에 8,140만 달러의 수익을 보고했으며, 이는 2023년 3분기 대비 19% 증가한 수치입니다. 수익 분해: 캘리포니아 에탄올 사업은 4,500만 달러, 인도 바이오디젤 사업은 3,220만 달러, 그리고 유제품 재생 가능 천연가스(RNG) 사업은 420만 달러를 생성했습니다. 회사는 390만 달러의 총 이익과 1,790만 달러의 순손실을 기록했습니다. 키예스 공장은 1,550만 갤런의 에탄올을 생산했으며, 유제품 천연가스 부문은 9개의 운영 중인 유제품 소화기에서 85,993 MMBtu를 판매했습니다. 분기 말 회사의 현금 위치는 29만 6천 달러였으며, 2024년 3분기 동안 자본 프로젝트에 450만 달러를 투자했습니다.

Aemetis (NASDAQ: AMTX) a annoncé des revenus de 81,4 millions de dollars pour le troisième trimestre 2024, soit une augmentation de 19 % par rapport au troisième trimestre 2023. Répartition des revenus : l'activité d'éthanol en Californie a généré 45,0 millions de dollars, l'activité de biodiesel en Inde 32,2 millions de dollars et l'activité de gaz naturel renouvelable (RNG) provenant des produits laitiers 4,2 millions de dollars. L'entreprise a enregistré un bénéfice brut de 3,9 millions de dollars et une perte nette de 17,9 millions de dollars. L'usine de Keyes a produit 15,5 millions de gallons d'éthanol, tandis que le segment du gaz naturel laitier a vendu 85,993 MMBtu provenant de neuf digesteurs laitiers en fonctionnement. La position de trésorerie de l'entreprise à la fin du trimestre était de 296 000 dollars, avec 4,5 millions de dollars investis dans des projets d'investissement au cours du troisième trimestre 2024.

Aemetis (NASDAQ: AMTX) berichtete von Umsätzen im dritten Quartal 2024 in Höhe von 81,4 Millionen US-Dollar, was einem Anstieg von 19% im Vergleich zum dritten Quartal 2023 entspricht. Umsatzaufteilung: Das Ethanol-Geschäft in Kalifornien erzielte 45,0 Millionen US-Dollar, das Biodiesel-Geschäft in Indien 32,2 Millionen US-Dollar und das Geschäft mit erneuerbarem Erdgas (RNG) aus der Milchindustrie 4,2 Millionen US-Dollar. Das Unternehmen meldete einen Bruttogewinn von 3,9 Millionen US-Dollar und einen Nettverlust von 17,9 Millionen US-Dollar. Das Keyes-Werk produzierte 15,5 Millionen Gallonen Ethanol, während der Bereich der Milch-Erdgas-Produktion 85.993 MMBtu aus neun betriebenen Milchdigestoren verkaufte. Die Kassenposition des Unternehmens zum Quartalsende betrug 296.000 US-Dollar, mit 4,5 Millionen US-Dollar, die im dritten Quartal 2024 in Kapitalprojekte investiert wurden.

Positive
  • Revenue increased 19% year-over-year to $81.4 million
  • Gross profit improved to $3.9 million from $492,000 in Q3 2023
  • Operating loss decreased to $3.9 million from $8.5 million in Q3 2023
  • SG&A expenses decreased to $7.8 million from $9.0 million in Q3 2023
Negative
  • Net loss of $17.9 million compared to net income of $30.7 million in Q3 2023
  • Interest expense increased to $11.7 million from $10.2 million in Q3 2023
  • Cash position decreased to $296,000 from $2.7 million at end of Q4 2023
  • Year-to-date net loss increased to $71.3 million from $21.0 million in 2023

Insights

The Q3 2024 results show mixed signals. While revenues increased 19% year-over-year to $81.4 million, the company reported a net loss of $17.9 million, contrasting with net income of $30.7 million in Q3 2023. The revenue growth across all segments is positive, but high interest expenses of $11.7 million and operating losses of $3.9 million remain concerning. Cash position is critically low at $296,000, down from $2.7 million at end of 2023. The recent CARB approval of 20-year LCFS mandates could provide future revenue stability, but immediate financial health concerns persist given the substantial debt burden and weak cash position.

The multi-segment growth strategy shows promise, with ethanol generating $45 million, biodiesel $32.2 million and RNG $4.2 million in revenues. The RNG segment's expansion to nine operating dairy digesters and pending LCFS provisional pathway approvals could unlock significant value. The 20-year CARB LCFS mandate provides long-term market stability for all renewable products. However, execution risks remain high given the capital-intensive nature of these projects and the company's tight liquidity. The India subsidiary's planned IPO could provide needed capital, but timing and success are uncertain.

Revenues Increased 19% Over the Third Quarter of 2023

CUPERTINO, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on low and negative carbon intensity products that replace fossil fuels, today announced its financial results for the three and nine months ended September 30, 2024.

Revenues of $81.4 million for the third quarter of 2024 reflect strong execution by all three of the company’s operating segments, with the California Ethanol business generating $45.0 million in revenues, the India Biodiesel business generating $32.2 million in revenues, and the Dairy Renewable Natural Gas (RNG) business generating $4.2 million in revenues.

“Each of the Aemetis segments increased revenue during the third quarter of 2024 compared to the second quarter of 2024, reflecting underlying strength and growth,” stated Todd Waltz, Chief Financial Officer of Aemetis. “Additionally, we anticipate substantial revenue growth from our operating dairies and new dairies under construction when we receive LCFS provisional pathway approvals as well as federal Inflation Reduction Act (IRA) 45Z production tax credits for RNG,” added Waltz.

“The approval of 20 years of Low Carbon Fuel Standard mandates last Friday by CARB is a major milestone for renewable fuels that directly increases revenues and earnings from each of our U.S. businesses and projects in ethanol, biogas, SAF/RD and carbon sequestration,” said Eric McAfee, Chairman and CEO of Aemetis.  “In addition to solid growth in our U.S. businesses, our India subsidiary generated $112 million of revenues driven by the one-year, cost-plus contract with government-owned oil marketing companies that ended in Q3 2024, and we appointed a Chief Executive Officer for the India business who is leading our work towards an IPO of the subsidiary.”

We invite investors to review the Aemetis Corporate Presentation on the Aemetis home page prior to the earnings call.

Today, Aemetis will host an earnings review call at 11:00 a.m. Pacific time (PT).

Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 139838
Live Participant Dial In (International): +1-973-528-0011 entry code 139838

Webcast URL:  https://www.webcaster4.com/Webcast/Page/2211/51559

For details on the call, please visit http://www.aemetis.com/investors/conference-calls/

Financial Results for the Three Months Ended September 30, 2024

Revenues during the third quarter of 2024 were $81.4 million compared to $68.7 million for the third quarter of 2023. Our Keyes plant recognized $45.0 million of revenue during the third quarter with the production of 15.5 million gallons of ethanol. Our Dairy Natural Gas segment sold 85,993 MMBtu from nine operating dairy digesters and also sold 935 thousand RINs and 20 thousand metric tons of LCFS credits to report $4.2 million of revenue during the third quarter. Our India Biodiesel business recognized $32.2 million of revenue primarily from sales to the India Oil Marketing Companies.

Gross profit for the third quarter of 2024 was $3.9 million, compared to a $492 thousand profit during the third quarter of 2023.

Selling, general and administrative expenses were $7.8 million during the third quarter of 2024 compared to $9.0 million during the same period in 2023, the decrease in spending was driven primarily by professional services associated with the sale of tax credits during the third quarter of 2023.

Operating loss was $3.9 million for the third quarter of 2024, compared to operating loss of $8.5 million for the same period in 2023.

Interest expense, excluding accretion of Series A preferred units in the Aemetis Biogas LLC subsidiary, increased to $11.7 million during the third quarter of 2024 compared to $10.2 million during the third quarter of 2023. Additionally, Aemetis Biogas recognized $3.3 million of accretion of Series A preferred units during the third quarter of 2024 compared to $7.7 million during the third quarter of 2023.

Net loss was $17.9 million for the third quarter of 2024, compared to net income of $30.7 million for the third quarter of 2023.

Cash at the end of the third quarter of 2024 was $296 thousand compared to $2.7 million at the close of the fourth quarter of 2023. We recorded investments in capital projects related to the reduction of the carbon intensity of Aemetis ethanol and construction of dairy digesters of $4.5 million for the third quarter of 2024.

Financial Results for the Nine Months Ended September 30, 2024

Revenues were $220.6 million for the first three quarters of 2024, compared to $116.0 million for the first three quarters of 2023. The increase in revenue in 2024 was due to strong performance from California Ethanol, India Biodiesel, and Dairy Renewable Natural Gas throughout the nine months of 2024 compared to the same period of 2023.

Gross profit for the first three quarters of 2024 was $1.5 million, compared to a gross profit of $1.2 million during the first three quarters of 2023.

Selling, general and administrative expenses were $28.4 million during the first three quarters of 2024, compared to $29.6 million during the first three quarters of 2023, including $4.0 million of fixed costs of goods sold charged to selling, general and administrative during the Keyes plant maintenance period during 2023 and the recognition of a loss on asset disposals of $3.6 million during 2024.

Operating loss was $26.9 million for the first three quarters of 2024, compared to $28.4 million for the first three quarters of 2023.

Interest expense was $34.0 million during the first three quarters of 2024, excluding accretion and other expenses of Series A preferred units in our Aemetis Biogas LLC subsidiary, compared to interest expense of $28.9 million during the first three quarters of 2023. Additionally, our Aemetis Biogas LLC subsidiary recognized $10.1 million of accretion and other expenses in connection with preference payments on its preferred stock during the first three quarters of 2024 compared to $20.2 million during the first three quarters of 2023.

Net loss for the first three quarters of 2024 was $71.3 million, compared to a net loss of $21.0 million during the same period of 2023.

Investments in capital projects of $13.5 million were made during the first three quarters of 2024, including investments in capital projects related to Aemetis Biogas of $10.9 million.

About Aemetis

Headquartered in Cupertino, California, Aemetis is a renewable natural gas, renewable fuel and biochemicals company focused on the operation, acquisition, development, and commercialization of innovative technologies that replace petroleum-based products and reduce greenhouse gas emissions. Founded in 2006, Aemetis is operating and actively expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas. Aemetis owns and operates a 65 million gallon per year ethanol production facility in California’s Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis owns and operates a 60 million gallon per year production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis is developing a sustainable aviation fuel (SAF) and renewable diesel fuel biorefinery in California to utilize renewable hydrogen, hydroelectric power, and renewable oils to produce low carbon intensity renewable jet and diesel fuel. For additional information about Aemetis, please visit www.aemetis.com.

Non-GAAP Financial Information

We have provided non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data. Adjusted EBITDA is defined as net income/(loss) plus (to the extent deducted in calculating such net income) interest expense, income tax expense, intangible and other amortization expense, accretion expense, depreciation expense, loss on asset disposal, gain on debt extinguishment, USDA cash grants and share-based compensation expense.

Safe Harbor Statement

This news release contains forward-looking statements, including statements regarding assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements include, without limitation, projections of financial results in 2024 and future years; statements relating to the development, engineering, financing, construction and operation of the Aemetis ethanol, biodiesel, biogas, SAF and renewable diesel, and carbon sequestration facilities; and our ability to promote, develop and deploy technologies to produce renewable fuels and biochemicals. Words or phrases such as “anticipates,” “may,” “will,” “should,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “showing signs,” “targets,” “view,” “will likely result,” “will continue” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Reports on Form 10-K, and in our other filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.

External Investor Relations
Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
ksmith@pcgadvisory.com

Investor Relations/
Media Contact:
Todd Waltz
(408) 213-0940
investors@aemetis.com

(Tables follow)

AEMETIS, INC.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(unaudited, in thousands, except per share data)

  For the three months ended
September 30,
  For the nine months ended
September 30,
 
  2024  2023  2024  2023 
Revenues $81,441  $68,690  $220,636  $115,953 
Cost of goods sold  77,563   68,198   219,176   114,800 
Gross profit  3,878   492   1,460   1,153 
                 
Selling, general and administrative expenses  7,750   9,021   28,400   29,595 
Operating loss  (3,872)  (8,529)  (26,940)  (28,442)
                 
Other expense (income):                
Interest expense                
Interest rate expense  10,096   8,749   29,092   24,126 
Debt related fees and amortization expense  1,651   1,433   4,892   4,732 
Accretion and other expenses of Series A preferred units  3,267   7,739   10,055   20,188 
Other income  (1,225)  (1,853)  (1,176)  (2,020)
Loss before income taxes  (17,661)  (24,597)  (69,803)  (75,468)
Income tax expense (benefit)  274   (55,308)  1,537   (54,490)
Net Income (loss) $(17,935) $30,711  $(71,340) $(20,978)
                 
Net Income (loss) per common share                
Basic $(0.38) $0.79  $(1.60) $(0.56)
Diluted $(0.38) $0.73  $(1.60) $(0.56)
                 
Weighted average shares outstanding                
Basic  47,216   38,881   44,517   37,504 
Diluted  47,216   41,841   44,517   37,504 


AEMETIS, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(in thousands)

  September 30, 2024  December 31, 2023 
  (Unaudited)     
Assets        
Current assets:        
Cash and cash equivalents $296  $2,667 
Accounts receivable  8,027   8,633 
Inventories  19,792   18,291 
Prepaid and other current assets  6,785   6,809 
Total current assets  34,900   36,400 
         
Property, plant and equipment, net  195,939   195,108 
Other assets  16,586   11,898 
Total assets $247,425  $243,406 
         
Liabilities and stockholders' deficit        
Current liabilities:        
Accounts payable $37,254  $32,132 
Current portion of long term debt  55,797   13,585 
Short term borrowings  21,418   23,443 
Other current liabilities  17,773   15,229 
Total current liabilities  132,242   84,389 
         
Total long term liabilities  374,092   375,994 
         
Stockholders' deficit:        
Common stock  48   41 
Additional paid-in capital  293,611   264,058 
Accumulated deficit  (546,745)  (475,405)
Accumulated other comprehensive loss  (5,823)  (5,671)
Total stockholders' deficit  (258,909)  (216,977)
Total liabilities and stockholders' deficit $247,425  $243,406 


RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME/(LOSS)
(unaudited, in thousands)

  For the three months ended
September 30,
  For the nine months ended
September 30,
 
EBITDA Calculation 2024  2023  2024  2023 
                 
Net income (loss) $(17,935) $30,711   (71,340)  (20,978)
Adjustments                
Interest and amortization expense  11,747   10,182   33,984   28,858 
Depreciation expense  2,274   1,747   6,121   5,208 
Accretion of Series A preferred units  3,267   7,739   10,055   20,188 
Loss on asset disposal  -   -   3,644   - 
Gain on debt extinguishment  (162)  -   (162)  - 
Share-based compensation  1,982   1,806   6,928   6,223 
Intangibles amortization expense  12   11   36   35 
USDA cash grants  -   (1,774)  -   (1,774)
Income tax expense  274   (55,308)  1,537   (54,490)
Total adjustments  19,394   (35,597)  62,143   4,248 
                 
Adjusted EBITDA $1,459  $(4,886)  (9,197)  (16,730)


PRODUCTION AND PRICE PERFORMANCE
(unaudited)

  Three Months ended
September 30,
  Nine Months ended
September 30,
 
  2024  2023  2024  2023 
Ethanol                
Gallons sold (in millions)  15.5   13.8   44.4   16.7 
Average sales price/gallon $2.12  $2.64  $1.97  $2.72 
Percent of nameplate capacity  113%  100%  108%  91%
WDG                
Tons sold (in thousands)  106   98.0   305   122.0 
Average sales price/ton $84  $96  $90  $98 
Delivered Cost of Corn                
Bushels ground (in millions)  5.5   5.0   15.6   6.4 
Average delivered cost / bushel $6.07  $7.48  $6.25  $7.34 
Dairy Renewable Natural Gas                
MMBtu produced (in thousands)  86.6   66.6   236.3   142.0 
MMBtu stored as inventory (in thousands)  67.6   67.2   67.6   67.2 
MMBtu sold (in thousands)  86.0   66.6   234.8   142.0 
Biodiesel                
Metric tons sold (in thousands)  26.0   15.5   73.5   42.1 
Average Sales Price/Metric ton $1,198  $1,247  $1,167  $1,265 
Percent of Nameplate Capacity  69.3%  41.0%  65.4%  21.0%
Refined Glycerin                
Metric tons sold (in thousands)  1.5   1.4   5.4   2.9 
Average Sales Price/Metric ton $720  $623  $621  $651 

FAQ

What was Aemetis (AMTX) revenue in Q3 2024?

Aemetis reported revenues of $81.4 million in Q3 2024, representing a 19% increase from Q3 2023.

How much ethanol did Aemetis (AMTX) Keyes plant produce in Q3 2024?

The Keyes plant produced 15.5 million gallons of ethanol in Q3 2024, generating $45.0 million in revenue.

What was Aemetis (AMTX) net loss in Q3 2024?

Aemetis reported a net loss of $17.9 million for Q3 2024, compared to net income of $30.7 million in Q3 2023.

How much revenue did Aemetis (AMTX) India Biodiesel business generate in Q3 2024?

Aemetis' India Biodiesel business generated $32.2 million in revenues during Q3 2024.

Aemetis, Inc. (DE)

NASDAQ:AMTX

AMTX Rankings

AMTX Latest News

AMTX Stock Data

180.76M
45.77M
7.97%
22.82%
14.3%
Oil & Gas Refining & Marketing
Industrial Organic Chemicals
Link
United States of America
CUPERTINO